Inactive Instrument

Highlights SofWave Medical Ltd. TEL AVIV STOCK EXCHANGE

Equities

Sofwave Medical Ltd Receives Marketing Clearance in Canada for Pure Impact? Strength and Muscle Toning Device	06-11	CI
SofWave Medical Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
SofWave Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-06	CI
Sofwave Medical Receives 510(K) Marketing Clearance for Pure Impact Strength and Muscle Toning Body Module Utilizing Plyopulse EMS Technology	01-03	CI
SofWave Medical Ltd. Receives FDA Clearance of Superb?? Technology for Improvement of the Appearance of Skin Laxity on the Upper Arm	12-26	CI
SofWave Medical Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08	CI
Sofwave Medical Announces FDA Clearance of SUPERB? Technology For Treatment of Acne Scars	30/08/23	CI
SofWave Medical Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/08/23	CI
Sofwave Medical Ltd. Gains Additional U.S. Patent Protection for the Company's Proprietary SUPERBâ„¢ Technology	05/07/23	CI
SofWave Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	08/03/23	CI

No results for this search